Bromodomain Containing Protein 2 - Drugs In Development, 2021

Published	Pages	Publisher	Report code
Jun 2021	82	Global Markets Direct	ASDR-585308

Published: Jun 2021 - Pages : 82 - Publisher : Global Markets Direct - Report code : ASDR-585308

AbbVie Inc
Amgen Inc
Boehringer Ingelheim International GmbH
Boston Pharmaceuticals Inc
Bristol-Myers Squibb Co
Constellation Pharmaceuticals Inc
In4Derm?Ltd
Ningbo Wenda Pharmaceutical Technology Co Ltd
Zenith Epigenetics Ltd

Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) Development by Therapy Areas...

Published: March, 2022 | Report code: ASDR-599158

Mark your calendar:

Veterans Affairs Healthcare Summit

23 July - 24 July, 2024
Arlington, United States